International Event

The aim of this multi-disciplinary conference is to understand dementia in Down syndrome at the neurological, cognitive, behavioural, cellular and genetic levels. More information regarding the meeting may be found at https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=378

The conference will highlight the following themes: Prevention & treatment, small vessel disease, post-stroke dementia, vascular factors in dementia, classifying vascular cognitive disorders and vascular psychiatric syndromes.

More information may be found at www.vascog2013.com/

Building on the success of its previous conferences in Xiamen (China) in 2009 and Shanghai (China) in 2011, BioMed Central will host world-renowned experts on the latest research in uncovering the molecular mechanisms underlying age-related neurodegenerative diseases.

More information regarding the converence may be found at http://conf.molecularneurodegeneration.com/

Join international colleagues at a 2-day conference on the latest updates on the use of PET & MR imaging as early diagnostic biomarkers in a variety of neurological and psychiatric disorders.

More preliminary information on the conference may be found at www.neuroimage.fr/Preliminary-program-2013-ECCN_a21.html

This conference is sponsored by the non-profit Gordon Research Conferences organization and will feature 9 thematic sessions that focus on bioenergetic deficits, activation of inflammatory responses, and white matter metabolism in brain aging and Alzheimer's disease.

More information may be found at www.grc.org/programs.aspx?year=2013&program=oxidat

An Oxidative Stress and Disease Gordon Research Seminar will be held in conjunction with the conference. More information may be found at www.grc.org/programs.aspx?year=2013&program=grs_oxidat

Leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs will discuss the challenges associated with the discovery and validation of biomarkers for autism, Parkinson's disease, Alzheimer's disease, multiple sclerosis and schizophrenia.

More information may be found at https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=303. A draft program is attached.

New developments in the study of dementia will be showcased, along with opportunities to meet leading clinicians and reserachers in the field of vascular dementia.

More information may be found at www2.kenes.com/vascular/Pages/Home.aspx

The symposium will be sponsored by the Southern Illinois University School of Medicine and the University of Geneva Medical School. Leading scientists will discuss new targets and drugs for treating Alzheimer's disease. More information regarding the event may be found at www.siumed.edu/cme/alzheimer/.

A variety of panel discussions will focus on novel therapeutic approaches to Alzheimer's disease.More information may be found at www.ad-zuers.com.

Supported by the Uppsala University, Uppsala University Hospital and the Swedish Research Council, the 2-day conference will present the latest findings on immunotherapy and biomarkers for a variety of neurodegenerative disorders.

More preliminary information may be found at

www.trippus.se/web/Presentation/web.aspx?evid=utbEg0IBgFKnzfy2X5IJtA==&ecid=HIpB+qo83e9Y+BXcZqe6cQ==&ln=eng&emid=zoybidHLWQG9IKRJYhQlaQ==&view=infopage&template=flex